Julie Ehlers

The median overall survival was 34.4 months in patients who received radiotherapy plus icotinib and 26.2 months in those who received icotinib alone.

Psilocybin-assisted psychotherapy can help patients with cancer with a range of psychiatric symptoms, according to a recent study.

The median overall survival was 66.2 months with perioperative chemotherapy, 43.9 months with trimodality therapy, 18.1 months with definitive chemoradiotherapy, and 13.5 months with radiotherapy alone.

Medicaid expansion was associated with a slower decrease in receipt of guideline-concordant treatment, reduced delays in treatment initiation, and improved 2-year survival, according to researchers.

New data suggest that supply chain issues are more likely to result in drug shortages in the United States than in Canada. In both countries, shortages are more likely for drugs with a single manufacturer than for drugs with multiple manufacturers. These findings were published in JAMA.

Four pesticides — cloransulam‐methyl, diflufenzopyr, thiamethoxam, and trifluralin — were positively associated with prostate cancer incidence and death.

“Frontline pembrolizumab has consistent antitumor activity and safety in patients with advanced UC [urothelial carcinoma] categorized as potentially ineligible for platinum‐based chemotherapy, regardless of the variable definitions of platinum ineligibility used,” the researchers concluded.

As many as 40% of cancer patients receiving immune checkpoint inhibitors (ICIs) experience immune-related adverse events (AEs), according to results of a systematic review published in the British Journal of Cancer

Experienced dermatologists provide more accurate diagnoses than inexperienced dermatologists or primary care providers, and the use of in-person examination plus dermoscopy can provide the most accurate results, researchers found.